Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Henderson Insider Profile
11 Followers
John Henderson, Director at Myriad Genetics, holds 48.64K shares in Cytokinetics (Ticker: CYTK), holds 78.09K shares in Myriad Genetics (Ticker: MYGN).
Profitable Transactions
6 out of 8 Profitable Transactions
Average Return
+24.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Henderson holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Henderson
John Henderson's Trading History
Myriad Genetics
Dec 06, 2019
Director
Uninformative Buy
―
$1.04M
Cytokinetics
Dec 12, 2024
Director
Uninformative Buy
87.50K
$2.38M
List of latest transactions for each holding click on a transaction to see John Henderson's performance on stock
You May Also Like
John Henderson insider profile FAQ
What is the percentage of profitable transactions made by John Henderson?
The percentage of profitable transactions made by John Henderson is 75%.
What is the average return per transaction made by John Henderson?
The average return per transaction made by John Henderson is 24.10%.
What stocks does John Henderson hold?
John Henderson holds: MYGN, CYTK stocks.
What was John Henderson’s latest transaction?
John Henderson latest transaction was an Uninformative Buy of $87.50K.
What was John Henderson's most profitable transaction?
John Henderson’s most profitable transaction was an Informative Buy of CYTK stock on January 2, 2020. The return on the trade was 96.90%.
What is John Henderson's role in Myriad Genetics?
John Henderson's role in Myriad Genetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.